Form 8-K - Current report:
SEC Accession No. 0001104659-25-046155
Filing Date
2025-05-08
Accepted
2025-05-08 16:25:47
Documents
17
Period of Report
2025-05-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2514493d1_8k.htm   iXBRL 8-K 41865
2 EXHIBIT 5.1 tm2514493d1_ex5-1.htm EX-5.1 14621
3 EXHIBIT 99.1 tm2514493d1_ex99-1.htm EX-99.1 99144
7 GRAPHIC tm2514493d1_ex5-1img001.jpg GRAPHIC 5430
8 GRAPHIC tm2514493d1_ex99-1img001.jpg GRAPHIC 5057
  Complete submission text file 0001104659-25-046155.txt   367316

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA elut-20250508.xsd EX-101.SCH 3005
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE elut-20250508_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elut-20250508_pre.xml EX-101.PRE 22352
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2514493d1_8k_htm.xml XML 3817
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
ELUTIA INC. (Filer) CIK: 0001708527 (see all company filings)

EIN.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39577 | Film No.: 25926674
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)